AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 10360847
Drug: Nitroglycerin Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin Group (NG) - 5 mg nitroglycerin patch daily
Trial: 10360847
Drug: Ketamine Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine Group (KG) - 0.5 mg/kg oral ketamine at 12-h intervals
Trial: 8839554
Drug: Omeprazole, 20
RxNorm normalized name: Omeprazole, 20 mg oral delayed release tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole, 20 mg once a day
Trial: 8839554
Drug: Placebo, 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, 1 tablet twice a day
Trial: 8839554
Drug: Misoprostol, 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol, 400 micrograms twice a day
Trial: 6389394
Drug: Antimicrobial agents
RxNorm normalized name: GAUZE,ANTIMICROBIAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antimicrobial agents (antibiotics)
Trial: 1971320
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg mifepristone, given orally 48 h before surgery
Trial: 25150401
Drug: AA attendance
RxNorm normalized name: zinc oxide
DrugBank: Zinc oxide (DB09321)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: AA attendance during treatment (12 weeks of outpatient treatment)
Trial: 21676165
Drug: Active placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active placebo (12.5 mg diphenhydramine)
Trial: 19112061
Drug: Plain articaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain articaine 50 mg
Trial: 19112061
Drug: Plain prilocaine
RxNorm normalized name: Prilocaine
DrugBank: Prilocaine (DB00750)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Plain prilocaine 50 mg
Trial: 16680610
Drug: ROB‐ML (robotics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ROB‐ML (robotics and motor learning)
Trial: 16680610
Drug: FNS‐ML (functional
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FNS‐ML (functional neuromuscular stimulation and motor learning)
Trial: 9814448
Drug: Corticosteroid therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Corticosteroid therapy (methylprednisolone, 1 g i.v. for 2 consecutive days a week for 6 weeks)
Trial: 7657044
Drug: alpha‐interferon (IFN)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: alpha‐interferon (IFN) alfa‐2b (6 MU 3 times weekly for the first month and 3 MU for the next 11 months)
Trial: 27942999
Drug: Algorithm-based treatments
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Algorithm-based treatments (AT)
Trial: 15514382
Drug: Cancer consultation
RxNorm normalized name: Cancer/testis antigen 1
DrugBank: Cancer/testis antigen 1 (DB19291)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cancer consultation preparation package (CCPP)
Trial: 9393429
Drug: Increased awareness
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Increased awareness of tobacco use as a risk factor for osseointegration of dental implants
Trial: 8481628
Drug: Allopurinol (test
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Allopurinol (test preparation)
Trial: 24814528
Drug: pioglitazone 30
RxNorm normalized name: pioglitazone 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pioglitazone 30 mg/day
Trial: 22747647
Drug: Diflunisal administration
RxNorm normalized name: Diflunisal
DrugBank: Diflunisal (DB00861)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Diflunisal administration
Trial: 20727660
Drug: Anti-psychotic medication
RxNorm normalized name: pramoxine hydrochloride Medicated Pad [Scalpicin Anti-Itch]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-psychotic medication
Trial: 18850554
Drug: Nonpenetrating deep
RxNorm normalized name: Deep Sea
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonpenetrating deep sclerectomy (NPDS) with reticulated hyaluronic acid (SK-GEL) scleral implant
Trial: 18850554
Drug: Both NPDS
RxNorm normalized name: Bothrops atrox venom
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Both NPDS and PT (with Mitomycin C 0.2 mg/mL applied intraoperatively)
Trial: 1980278
Drug: Bisoprolol (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bisoprolol (20 mg QD)
Trial: 7461879
Drug: Short-term alcohol
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Short-term alcohol treatment intervention
Trial: 23565581
Drug: Combination duloxetine-methadone
RxNorm normalized name: methadone, combinations excl. psycholeptics
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination duloxetine-methadone
Trial: 19586568
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg lutein/d (Group L6)
Trial: 19586568
Drug: 12 mg
RxNorm normalized name: pectin 12 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 12 mg lutein/d (Group L12)
Trial: 9645459
Drug: Intrahepatic arterial
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrahepatic arterial infusion of 131I-radiolabelled anti-HCC monoclonal antibody (Hepama-1 mAb)
Trial: 9645459
Drug: Intrahepatic-arterial chemotherapy
RxNorm normalized name: Echinacea, aerial parts
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intrahepatic-arterial chemotherapy (non-RIT group)
Trial: 8194689
Drug: CCK-33 infusion
RxNorm normalized name: CCK-8
DrugBank: Sincalide (DB09142)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: CCK-33 infusion
Trial: 18333862
Drug: Maraviroc (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maraviroc (300 mg b.i.d.)
Trial: 9771399
Drug: Atropine (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atropine (15 micrograms/kg bolus intravenously, 4 micrograms/kg/h infusion)
Trial: 2891886
Drug: Acyclovir or
RxNorm normalized name: acyclovir Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir or vidarabine treatment for HSV-1 encephalitis
Trial: 2891886
Drug: Acyclovir or
RxNorm normalized name: acyclovir Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acyclovir or vidarabine treatment for HSV-2 encephalitis
Trial: 26628527
Drug: IVIG plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVIG plus cyclosporin A (CsA) (5 mg/kg/day for 5 days; Neoral) plus high-dose IVIG (2 g/kg for 24 h and aspirin 30 mg/kg/day)
Trial: 26628527
Drug: High-dose IVIG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose IVIG alone (2 g/kg for 24 h and aspirin 30 mg/kg/day)
Trial: 23800403
Drug: Esomeprazole 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Esomeprazole 0.5 mg/kg once daily for up to 14 days
Trial: 21968669
Drug: rosacea treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosacea treatment system (RTS)
Trial: 21968669
Drug: metronidazole 0.75%
RxNorm normalized name: METRONIDAZOLE 0.75% LOTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: metronidazole 0.75% gel plus standard skin care (M+SSC)
Trial: 16163443
Drug: Triamcinolon acetonide
RxNorm normalized name: Triamcinolone Acetonide
DrugBank: Triamcinolone (DB00620)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Triamcinolon acetonide 40 mg/ml plus lidocaine 2%
Trial: 2951805
Drug: disodium cromoglycate
RxNorm normalized name: Disodium cromoglycate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: disodium cromoglycate (DSCG) (10 mg)
Trial: 26766141
Drug: mongersen 40
RxNorm normalized name: Mongersen
DrugBank: Mongersen (DB15019)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mongersen 40 mg/day
Trial: 26766141
Drug: mongersen 160
RxNorm normalized name: Mongersen
DrugBank: Mongersen (DB15019)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mongersen 160 mg/day
Trial: 26766141
Drug: mongersen 10
RxNorm normalized name: Mongersen
DrugBank: Mongersen (DB15019)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mongersen 10 mg/day
Trial: 26766141
Drug: mongersen (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mongersen (all doses)
Trial: 22594467
Drug: Clonidine 3-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clonidine 3-4 μg kg(‐1) (C4)
Trial: 22594467
Drug: Clonidine 7-8
RxNorm normalized name: Clonidine
DrugBank: Clonidine (DB00575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Clonidine 7-8 μg kg(‐1) (C7)
Trial: 19859698
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine (0 mg)
Trial: 19859698
Drug: Intramuscular morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular morphine (5 mg and 10 mg)
Trial: 18022350
Drug: Lignocaine (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lignocaine (0.2 mL without vasoconstrictor)
Trial: 18022350
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline (0.2 mL)
Trial: 11079810
Drug: 0.2 U/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 U/kg x d ultralente insulin
Trial: 20881844
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER 12 mg/day
Trial: 20881844
Drug: Paliperidone ER
RxNorm normalized name: Paliperidone ER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paliperidone ER 18 mg/day
Trial: 19376787
Drug: Rocuronium 1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rocuronium 1.0 mg kg(‐1)
Trial: 15151527
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil (4 mg day(‐1))
Trial: 10886043
Drug: Anti-Helicobacter therapy
RxNorm normalized name: Helicobacter pylori
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anti-Helicobacter therapy in controls (D)
Trial: 1531719
Drug: Low-dose, intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose, intradermal hepatitis B vaccination (2 micrograms)
Trial: 1531719
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of 2 micrograms i.d.
Trial: 1531719
Drug: Low-dose, intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose, intradermal hepatitis B vaccination (3 doses at 0, 1, and 6 months)
Trial: 1531719
Drug: Low-dose, intradermal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-dose, intradermal hepatitis B vaccination (2 doses)
Trial: 1531719
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of 2 micrograms i.d. at month 25
Trial: 6357209
Drug: suprofen 200
RxNorm normalized name: suprofen 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: suprofen 200 mg
Trial: 3893444
Drug: pentazocine 30
RxNorm normalized name: pentazocine 30 MG/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: pentazocine 30 mg
Trial: 26996595
Drug: HDR (7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HDR (7 Gy each in three fractions, repeated weekly)
Trial: 26996595
Drug: PDR (70
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PDR (70 cGy hourly pulses for 39 hours, total 27 Gy)
Trial: 23732307
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of laninamivir octanoate once daily for 2 days (LO-2)
Trial: 23732307
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of laninamivir octanoate once daily for 3 days (LO-3)
Trial: 12862326
Drug: Acute caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acute caffeine consumption (5 mg x kg(‐1) body mass)
Trial: 12862326
Drug: Chronic caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic caffeine consumption (5 mg x kg(‐1) body mass for 7 days)
Trial: 27771748
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg oral d-amphetamine
Trial: 31340232
Drug: 1.0 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 mg/kg oral midazolam (first session)
Trial: 31340232
Drug: oral placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: oral placebo (first session)
Trial: 27926633
Drug: Hormone Therapy
RxNorm normalized name: INVESTIGATIONAL HORMONE THERAPY/REPLACEMENT,OTHER
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hormone Therapy
Trial: 27926633
Drug: Calcium+Vitamin D
RxNorm normalized name: Calcium/Cholecalciferol 500 MG-10 MCG Oral Tablet [LEADER CALCIUM+VITAMIN D3]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium+Vitamin D + Hormone Therapy
Trial: 19556262
Drug: Prednisone 1
RxNorm normalized name: prednisone 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prednisone 1 mg kg(‐1) day(‐1) for 4 weeks followed by 0.33 mg kg(‐1) day(‐1) for 5 months and azathioprine 2 mg kg(‐1) day(‐1) for 6 months (Group 1)
Trial: 17541639
Drug: MMRV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMRV vaccine co-administered with DTPa-HBV-IPV/Hib vaccine
Trial: 17541639
Drug: MMRV vaccine
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MMRV vaccine alone
Trial: 17541639
Drug: Booster dose
RxNorm normalized name: SARS-COV-2 (COVID-19) Vaccine, mRNA (Moderna) 50 MCG/0.5 ML Intramuscular Suspension [MODERNA COVID-19 VACCINE BOOSTER DOSE]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Booster dose of DTPa-HBV-IPV/Hib vaccine
Trial: 23142309
Drug: Pelargonium sidoides
RxNorm normalized name: PELARGONIUM SIDOIDES ROOT
DrugBank: Pelargonium sidoides root (DB16583)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pelargonium sidoides daily for 5 days (n=30)
Trial: 23142309
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment, n=31)
Trial: 16713009
Drug: valsartan 80
RxNorm normalized name: valsartan 80 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: valsartan 80 mg/day for 12 weeks
Trial: 16713009
Drug: Control (not
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (not administered valsartan)
Trial: 14716700
Drug: Galantamine (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Galantamine (up to 12 mg twice daily)
Trial: 9252210
Drug: Wheat bran
RxNorm normalized name: Wheat bran
DrugBank: Wheat bran (DB10685)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Wheat bran (mean intake 19.8 g day(-1))
Trial: 3325229
Drug: Isosorbide-5-mononitrate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (20 mg) - Group M2 (2 tablets per day)
Trial: 3325229
Drug: Isosorbide-5-mononitrate (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isosorbide-5-mononitrate (20 mg) - Group M3 (3 tablets per day)
Trial: 3325229
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate retard (40 mg) - Group D2 (2 tablets per day)
Trial: 3325229
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate retard (40 mg) - Group D3 (3 tablets per day)
Trial: 3325229
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate retard (40 mg)
Trial: 20220063
Drug: Imatinib high
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Imatinib high dose or 400 mg + interferon-alpha
Trial: 15562383
Drug: Transdermal estrogens
RxNorm normalized name: estrogens
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Transdermal estrogens (micronized 17beta‐estradiol; Systen, Janssen‐Cilag, Switzerland) and progesterone
Trial: 15562383
Drug: Oral hormones
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral hormones (Cyclo‐Menorette)
Trial: 10359391
Drug: Androstenedione 300
RxNorm normalized name: androstenedione
DrugBank: Androstenedione (DB01536)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Androstenedione 300 mg/d (n = 10)
Trial: 7727473
Drug: Ganciclovir (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir (5 mg/kg intravenously) given three times weekly for the first 6 weeks after transplantation and for another 2 weeks for each treated rejection episode between 6 and 12 weeks.
Trial: 7727473
Drug: Ganciclovir (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ganciclovir (10 mg/kg/day for 2 weeks)
Trial: 24899662
Drug: Allopurinol treatment
RxNorm normalized name: Allopurinol
DrugBank: Allopurinol (DB00437)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Allopurinol treatment (10 patients treated for 4 weeks)
Trial: 8777826
Drug: Losartan potassium,
RxNorm normalized name: Losartan Potassium, 25 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan potassium, 50 mg orally
Trial: 8777826
Drug: Enalapril, 20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril, 20 mg orally
Trial: 8777826
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of losartan and enalapril
Trial: 6094451
Drug: 1.0 g
RxNorm normalized name: IODINE 11.0 g in 1 L TOPICAL SOLUTION [T.D.]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.0 g cefotaxime before surgery
Trial: 6094451
Drug: 2.0 g
RxNorm normalized name: Fifty50 2.0 Glucose Meter
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2.0 g cefoxitin pre-operatively and every 8 h for no more than 24 h post-operatively
Trial: 27038786
Drug: i-Sleep (5-session
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i-Sleep (5-session guided online treatment)
Trial: 20345617
Drug: Intravenous prostaglandin
RxNorm normalized name: Prostaglandin D2
DrugBank: Prostaglandin D2 (DB02056)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous prostaglandin E1 (PGE) 60 microg in 100 mL saline
Trial: 15991504
Drug: Intravenous (i.v.)
RxNorm normalized name: immunoglobulins, intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous (i.v.) ketamine 0.15 mg kg(‐1) before induction and 2 microg kg(‐1) min(‐1) during anaesthesia
Trial: 12762609
Drug: 5% Eutectic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% Eutectic Mixture of Local Anesthetics (EMLA) cream applied for 3 minutes
Trial: 12762609
Drug: 5% Eutectic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% Eutectic Mixture of Local Anesthetics (EMLA) cream applied for 5 minutes
Trial: 12762609
Drug: 5% Eutectic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5% Eutectic Mixture of Local Anesthetics (EMLA) cream applied for 10 minutes
Trial: 10477166
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg i.m. daily (plus placebo)
Trial: 10477166
Drug: Granisetron 3
RxNorm normalized name: granisetron 3 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Granisetron 3 mg i.m. daily plus dexamethasone 8 and 4 mg twice daily
Trial: 6387892
Drug: Cephalexin (25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cephalexin (25-50 mg/kg body weight per day for 3 days)
Trial: 6387892
Drug: Nitrofurantoin (3-4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitrofurantoin (3-4 mg/kg/day for 10 days)
Trial: 31808408
Drug: Physical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Physical therapy (Group 2) - Two pre-RP physical therapist-guided PFMT sessions, including exercises and electromyographic biofeedback, and verbal and written instructions to continue PFMT until RP, which was then resumed after urethral catheter removal.
Trial: 22174437
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg) administered alone on day 4
Trial: 22174437
Drug: Pravastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pravastatin (40 mg) administered with darunavir/ritonavir (600/100 mg) on days 15-18
Trial: 7921798
Drug: 19% hydrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 19% hydrogen peroxide solution
Trial: 7921798
Drug: 35% hydrogen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35% hydrogen peroxide solution
Trial: 3713101
Drug: i.v. immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: i.v. immunoglobulin (4 X 100 ml) combined with antibiotics
Trial: 3713101
Drug: antibiotics alone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: antibiotics alone
Trial: 30968258
Drug: Cefotaxime 100–150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cefotaxime 100–150 mg/kg/day
Trial: 28523596
Drug: Vismodegib 150
RxNorm normalized name: vismodegib 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vismodegib 150 mg daily
Trial: 25857271
Drug: Plant stanol
RxNorm normalized name: plant stanol ester
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plant stanol group (n=46) consuming vegetable-oil spread enriched with plant stanols 3 g/day for 6 months
Trial: 21427402
Drug: Abacavir therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abacavir therapy
Trial: 21427402
Drug: No abacavir
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No abacavir therapy
Trial: 19773678
Drug: Antibiotic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antibiotic therapy (clarithromycin and rifabutin)
Trial: 15221494
Drug: Alfacalcidol 1
RxNorm normalized name: alfacalcidol 1 MCG Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfacalcidol 1 micro g/day with calcium for 6 months
Trial: 11592566
Drug: Growth hormone
RxNorm normalized name: Growth hormone
DrugBank: Somatotropin (DB00052)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Growth hormone therapy at a dose of 1.5 mg/m2/day